A comprehensive genomic analysis of more than 200 mesothelioma tumor samples has identified previously unknown genetic mutations, including several that may prove to be actionable right now for diagnosis and treatment of the deadly lung cancer, researchers say. Raphael Bueno (Brigham and Women’s) is lead author of the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?